228 related articles for article (PubMed ID: 9583077)
1. [Aldose reductase in the polyol pathway: a potential target for the therapeutic intervention of diabetic complications].
Nishimura-Yabe C
Nihon Yakurigaku Zasshi; 1998 Mar; 111(3):137-45. PubMed ID: 9583077
[TBL] [Abstract][Full Text] [Related]
2. Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems.
Niimi N; Yako H; Takaku S; Chung SK; Sango K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494154
[TBL] [Abstract][Full Text] [Related]
3. Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.
Huang Q; Liu Q; Ouyang D
Med Chem; 2019; 15(1):3-7. PubMed ID: 29792152
[TBL] [Abstract][Full Text] [Related]
4. Contribution of polyol pathway to diabetes-induced oxidative stress.
Chung SS; Ho EC; Lam KS; Chung SK
J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S233-6. PubMed ID: 12874437
[TBL] [Abstract][Full Text] [Related]
5. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase.
Jedziniak JA; Chylack LT; Cheng HM; Gillis MK; Kalustian AA; Tung WH
Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):314-26. PubMed ID: 6782033
[TBL] [Abstract][Full Text] [Related]
6. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
Suzen S; Buyukbingol E
Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
[TBL] [Abstract][Full Text] [Related]
7. All in the family: aldose reductase and closely related aldo-keto reductases.
Petrash JM
Cell Mol Life Sci; 2004 Apr; 61(7-8):737-49. PubMed ID: 15094999
[TBL] [Abstract][Full Text] [Related]
8. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
9. Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review.
Grewal AS; Thapa K; Kanojia N; Sharma N; Singh S
Curr Drug Metab; 2020; 21(14):1091-1116. PubMed ID: 33069193
[TBL] [Abstract][Full Text] [Related]
10. Contributions of polyol pathway to oxidative stress in diabetic cataract.
Lee AY; Chung SS
FASEB J; 1999 Jan; 13(1):23-30. PubMed ID: 9872926
[TBL] [Abstract][Full Text] [Related]
11. In Search of Differential Inhibitors of Aldose Reductase.
Balestri F; Moschini R; Mura U; Cappiello M; Del Corso A
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454074
[TBL] [Abstract][Full Text] [Related]
12. Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.
Thakur S; Gupta SK; Ali V; Singh P; Verma M
Arch Pharm Res; 2021 Jul; 44(7):655-667. PubMed ID: 34279787
[TBL] [Abstract][Full Text] [Related]
13. Aldose reductase expression as a risk factor for cataract.
Snow A; Shieh B; Chang KC; Pal A; Lenhart P; Ammar D; Ruzycki P; Palla S; Reddy GB; Petrash JM
Chem Biol Interact; 2015 Jun; 234():247-53. PubMed ID: 25541468
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase catalysis and crystallography. Insights from recent advances in enzyme structure and function.
Petrash JM; Tarle I; Wilson DK; Quiocho FA
Diabetes; 1994 Aug; 43(8):955-9. PubMed ID: 8039602
[TBL] [Abstract][Full Text] [Related]
15. A new approach to control the enigmatic activity of aldose reductase.
Del-Corso A; Balestri F; Di Bugno E; Moschini R; Cappiello M; Sartini S; La-Motta C; Da-Settimo F; Mura U
PLoS One; 2013; 8(9):e74076. PubMed ID: 24019949
[TBL] [Abstract][Full Text] [Related]
16. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.
ElGamal H; Munusamy S
Protein Pept Lett; 2017; 24(1):71-77. PubMed ID: 27894247
[TBL] [Abstract][Full Text] [Related]
17. Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors.
Madhu SV; Verma NP; Goel A; Kapoor VK
J Assoc Physicians India; 1992 Oct; 40(10):679-81. PubMed ID: 1307356
[No Abstract] [Full Text] [Related]
18. Aldose reductase and its inhibition in the control of diabetic complications.
Narayanan S
Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
[TBL] [Abstract][Full Text] [Related]
19. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibitors.
Oka M; Kato N
J Enzyme Inhib; 2001 Dec; 16(6):465-73. PubMed ID: 12164386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]